New Services

High Affinity Screening

Never miss a high-affinity antibody again. Many methods are only applied after final antibody selection. ImmunoPrecise allows screening at a very early stage without need for pure, known quantities of mAb and without the need of Surface Plasmon Resonance and BEFORE any clones are disregarded during the early selection process.

Promotions

Amazon.com gift card Spring promotion

$100 Amazon.com gift card Spring promotion for every new custom mAb project started from Feb 1st until Jun 30th, 2011.

Accolades

Customer Feedback

Listen to what IPA's existing & past customers have to say about our products & custom antibody development services.

Accreditation

National Institutes of Health

IPA is a compliant member by the Office of Laboratory Animal Welfare (OLAW) of the the Department of Health and Human Services (HHS), USA and has been awarded with a 5-year Animal Welfare Assurance Number.

Canadian Council on Animal Care

IPA is a member of the the Canadian Council on Animal Care. The CCAC provides certification and policies on ethical animal care and use.

Better Business Bureau

IPA is a member of the Better Business Bureau. The BBB is a private, non-profit organization, dedicated to promoting fairness and honesty in the marketplace.

Citations

Peer Reviewed Publications

Review the expanding list of publications sourcing IPA's catalog products & exclusively developed custom mAb hybridomas.

Quick Links

Quote Request Form

To expedite receiving a quote from IPA for your custom antibody development project, fill in the on-line submission form or download the following form and email or fax to (250) 483-0309. Quotes issued in less than 24 hrs.

Product Order Form

To order any of IPA's antibody products, download the following form and email or fax to (250) 483-0309. Confirmation in less than 24 hrs.

Antigen Information Sheet

To initiate the immunization phase of your custom antibody development project, download the following form and submit it with the shipment of your antigen.

IPA has two main competitive advantages over our competitors.

Rapid Prime - Clones In 65 Days

Our new “rapid-prime” inoculation method immunizes the mice in less than two weeks without limiting affinity maturation of the B-cells. This procedure works especially well with fusion proteins and it consistently produces mAbs of all isotypes. Because of this unique method, we can generate cloned mAbs in a total of sixty-five (65) days...

»  Show Details  |  Hide Details

(including immunization time) for most antigens. Other companies take five-eight months to deliver mAbs--this faster protocol will allow our clients to conduct their research or market their valuable mAbs with the least possible delay. One unexpected benefit of our “rapid-prime” process is that it has produced mAbs to poor immunogens when standard techniques have failed repeatedly. Our new “rapid-prime” inoculation method immunizes the mice in less than two weeks without limiting affinity maturation of the B-cells. This procedure works especially well with fusion proteins and it consistently produces mAbs of all isotypes. Because of this unique method, we can generate cloned mAbs in a total of 65 days (including immunization time) for most antigens. Other companies take five-eight months to deliver mAbs--this faster protocol will allow our clients to conduct their research or market their valuable mAbs with the least possible delay. One unexpected benefit of our “rapid-prime” process is that it has produced mAbs to poor immunogens when standard techniques have failed repeatedly.

Clone-Ez - Detect Rare & Slow Growing Clones

IPA has developed and perfected proprietary technology to generate mAbs significantly faster than other less sophisticated antibody companies.

Our specialized semi-solid hybridoma growth media, “Clone-EZ”, is a 1-step fusion and cloning media, which has several advantages over standard hybridoma selection and cloning methods, including:

»  Show Details  |  Hide Details

• Selection and cloning of hybridomas are performed in one step thus minimizing time and materials required.

• Plating of initial fusion mixture and simultaneous cloning are performed in minutes as compared to hours when using conventional methods.
• Growth conditions have been optimized to give high plating efficiency ensuring maximum hybridoma yield.
• Large numbers of hybridomas can be selected and tested.
• One to two thousand individual clones can be grown in twelve 60 mm petri dishes in a single step.
• Direct cloning eliminates overgrowth of some hybridomas thereby allowing the selection of valuable slow-growing colonies (this is not possible by any other method).
• Undesirable fibroblasts do not grow in this medium.
• Contamination of cultures is minimized because of fewer manipulations - little maintenance of cultures is required.
• The amount of testing is decreased since multiple identical clones are not produced as in suspension cultures.
• Recloning is not usually necessary.
• The procedure results in estimated savings of 18-20 days.
• Isolation of rare hybridomas secreting antibodies to minor antigens in complex mixtures.

 

 

Overall, our dedication to the advancement of new methodology has resulted in the development of an effortless cloning procedure which eliminates months of tedious dilution cloning. This technical refinement gives IPA a distinct edge over less progressive companies.

 

Copyright © 2011 ImmunoPrecise Antibodies Ltd.